Correction: HER2 as a Promising Target for Cytotoxicity T Cells in Human Melanoma Therapy.

Correction: HER2 as a Promising Target for Cytotoxicity T Cells in Human Melanoma Therapy.

Bibliographic Details
Main Authors:	Juan Ma, Huamin Han, Deruo Liu, Wei li, Hongxiang Feng, Xin Xue, Xiaoran Wu, Ge Niu, Ge Zhang, Yunfeng Zhao, Changzhen Liu, Hua Tao, Bin Gao
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2013-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3774071

Similar Items

HER2 as a promising target for cytotoxicity T cells in human melanoma therapy.
by: Juan Ma, et al.
Published: (2013-01-01)

Correction: HER2 as a Promising Target for Cytotoxicity T Cells in Human Melanoma Therapy
Published: (2013-01-01)

Retargeting T cells for HER2-positive tumor killing by a bispecific Fv-Fc antibody.
by: Lei Wang, et al.
Published: (2013-01-01)

Promising and Minimally Invasive Biomarkers: Targeting Melanoma
by: Pavlina Spiliopoulou, et al.
Published: (2023-12-01)

Combined targeting of HER-2 and HER-3 represents a promising therapeutic strategy in colorectal cancer
by: Lena-Christin Conradi, et al.
Published: (2019-09-01)

Endocrine therapy plus HER2-targeted therapy, another favorable option for HR+/HER2+ advanced breast cancer patients
by: Yuehua Liang, et al.
Published: (2024-01-01)

Correction: Uniportal video-assisted anatomical segmentectomy: an analysis of the learning curve
by: Yu Han, et al.
Published: (2023-08-01)

Identification of an Immune-Related Prognostic Signature Associated With Immune Infiltration in Melanoma
by: Nian Liu, et al.
Published: (2020-08-01)

The extracellular vesicles targeting tumor microenvironment: a promising therapeutic strategy for melanoma
by: Yongmin Li, et al.
Published: (2023-07-01)

Lysine Demethylases: Promising Drug Targets in Melanoma and Other Cancers
by: Gaya Punnia-Moorthy, et al.
Published: (2021-06-01)

The Nrf2 inhibitor brusatol synergistically enhances the cytotoxic effect of lapatinib in HER2-positive cancers
by: Ziyin Tian, et al.
Published: (2022-08-01)

An anti-HER2 biparatopic antibody that induces unique HER2 clustering and complement-dependent cytotoxicity
by: Nina E. Weisser, et al.
Published: (2023-03-01)

Ferroptosis as a promising therapeutic strategy for melanoma
by: Na Ta, et al.
Published: (2023-09-01)

Focusing on NK cells and ADCC: A promising immunotherapy approach in targeted therapy for HER2-positive breast cancer
by: Feifei Li, et al.
Published: (2022-12-01)

Copolymer micelles function as pH-responsive nanocarriers to enhance the cytotoxicity of a HER2 aptamer in HER2-positive breast cancer cells
by: Shen Y, et al.
Published: (2018-01-01)

Cytotoxic T lymphocyte responses against melanocytes and melanoma
by: Schwartz Erich J, et al.
Published: (2011-07-01)

SWI/SNF complex, promising target in melanoma therapy: Snapshot view
by: Mahsa Mollapour Sisakht, et al.
Published: (2023-02-01)

The Challenges and the Promise of Molecular Targeted Therapy in Malignant Gliomas
by: Hongxiang Wang, et al.
Published: (2015-03-01)

Shall I Name Her “Wisdom” or “Elegance”? Naming in China
by: Ge Gao
Published: (2011-09-01)

Engineering adipocytes for targeting delivery of triptolide derivative and Ce6 for malignant melanoma cytotoxic-PDT synergistic strategy
by: Yunan Zhao, et al.
Published: (2023-04-01)

Circular RNAs: Promising Treatment Targets and Biomarkers of Ischemic Stroke
by: Guangchen Xu, et al.
Published: (2023-12-01)

A novel asymmetrical anti-HER2/CD3 bispecific antibody exhibits potent cytotoxicity for HER2-positive tumor cells
by: Shengnan Yu, et al.
Published: (2019-08-01)

Affibody-Derived Drug Conjugates Targeting HER2: Effect of Drug Load on Cytotoxicity and Biodistribution
by: Haozhong Ding, et al.
Published: (2021-03-01)

Targeting the FGFR signaling pathway in cholangiocarcinoma: promise or delusion?
by: Jing Wang, et al.
Published: (2020-07-01)

Correction: Withania somnifera Root Extract Has Potent Cytotoxic Effect against Human Malignant Melanoma Cells.
by: Babli Halder, et al.
Published: (2015-01-01)

lncRNAs-EZH2 interaction as promising therapeutic target in cutaneous melanoma
by: Michal Wozniak, et al.
Published: (2023-05-01)

Potential Cytotoxic Activity of Galegine on Human Melanoma Cells
by: Mohammad Hassan Arjmand, et al.
Published: (2022-07-01)

Anti-cytotoxic T lymphocyte antigen-4 antibodies in melanoma
by: Tosti G, et al.
Published: (2013-10-01)

Comprehensive Analysis of a Novel Immune-Related Gene Signature in Lung Adenocarcinoma
by: Hongxiang Feng, et al.
Published: (2022-10-01)

NOX4 Signaling Mediates Cancer Development and Therapeutic Resistance through HER3 in Ovarian Cancer Cells
by: Wen-Jing Liu, et al.
Published: (2021-06-01)

Synergistic Cytotoxic and Antimigratory Effect of Brazilein and Doxorubicin on HER2-Overexpressing Cells
by: Handayani, Sri, et al.
Published: (2022)

The Cytotoxic and Antimigratory Activity of Brazilin-Doxorubicin on MCF-7/HER2 Cells
by: Riris Istighfari Jenie, et al.
Published: (2018-08-01)

Epac: A Promising Therapeutic Target for Vascular Diseases: A Review
by: Yunfeng Pan, et al.
Published: (2022-07-01)

Development of a novel NiCu nanoparticle-loaded polysaccharide-based hydrogel for 3D printing of customizable dressings with promising cytotoxicity against melanoma cells
by: Laura Činč Ćurić, et al.
Published: (2023-10-01)

Correction to: ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity
by: Yann Cheli, et al.
Published: (2021-01-01)

Is Tissue Still the Issue? The Promise of Liquid Biopsy in Uveal Melanoma
by: Daniël P. de Bruyn, et al.
Published: (2022-02-01)

The Promise of Liquid Biopsy to Predict Response to Immunotherapy in Metastatic Melanoma
by: Luigi Fattore, et al.
Published: (2021-03-01)

HER2 status of CTCs by peptide-functionalized nanoparticles as the diagnostic biomarker of breast cancer and predicting the efficacy of anti-HER2 treatment
by: Mengting Wang, et al.
Published: (2022-09-01)

Correction: Frequent Mutations in Human Melanoma.
by: Otavia L. Caballero, et al.
Published: (2010-01-01)

Study of Cinobufagin as a Promising Anticancer Agent in Uveal Melanoma Through Intrinsic Apoptosis Pathway
by: Leilei Zhang, et al.
Published: (2020-04-01)